↓ Skip to main content

Dove Medical Press

Quaternized chitosan promotes the antiproliferative effect of vemurafenib in melanoma cells by increasing cell permeability

Overview of attention for article published in OncoTargets and therapy, November 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
3 X users
googleplus
2 Google+ users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
6 Mendeley
Title
Quaternized chitosan promotes the antiproliferative effect of vemurafenib in melanoma cells by increasing cell permeability
Published in
OncoTargets and therapy, November 2018
DOI 10.2147/ott.s183311
Pubmed ID
Authors

Min Li, Ying Yang

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 33%
Professor 1 17%
Student > Bachelor 1 17%
Researcher 1 17%
Unknown 1 17%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Biochemistry, Genetics and Molecular Biology 1 17%
Nursing and Health Professions 1 17%
Agricultural and Biological Sciences 1 17%
Chemistry 1 17%
Other 0 0%
Unknown 1 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2018.
All research outputs
#8,398,762
of 25,707,225 outputs
Outputs from OncoTargets and therapy
#499
of 3,013 outputs
Outputs of similar age
#141,317
of 364,643 outputs
Outputs of similar age from OncoTargets and therapy
#25
of 146 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,643 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 146 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.